325 related articles for article (PubMed ID: 25163664)
21. Protocol refinement for a diabetes pragmatic trial using the PRECIS-2 framework.
Glasgow RE; Gurfinkel D; Waxmonsky J; Rementer J; Ritchie ND; Dailey-Vail J; Hosokawa P; Dickinson LM; Kwan BM
BMC Health Serv Res; 2021 Oct; 21(1):1039. PubMed ID: 34598702
[TBL] [Abstract][Full Text] [Related]
22. PRECIS-2 analysis of pragmatic acupuncture trials: a systematic review.
Lim J; Lee H; Kim YS
BMC Complement Med Ther; 2024 May; 24(1):181. PubMed ID: 38702632
[TBL] [Abstract][Full Text] [Related]
23. Balancing Internal and External Validity Using Precis-2 and Re-Aim: Case Exemplars.
Wright PJ; Pinto BM; Corbett CF
West J Nurs Res; 2021 Feb; 43(2):163-171. PubMed ID: 32648834
[TBL] [Abstract][Full Text] [Related]
24. An application of PRECIS-2 to evaluate trial design in a pilot cluster randomised controlled trial of a community-based smoking cessation intervention for women living in disadvantaged areas of Ireland.
Darker C; Loudon K; O'Connell N; Castello S; Burke E; Vance J; Reynolds C; Buggy A; Dougall N; Williams P; Dobbie F; Bauld L; Hayes CB
Pilot Feasibility Stud; 2022 Jan; 8(1):19. PubMed ID: 35078530
[TBL] [Abstract][Full Text] [Related]
25. CHARTing a Path to Pragmatic Tobacco Treatment Research.
Cruvinel E; Richter KP; Stoney C; Duffy S; Fellows J; Harrington KF; Rigotti NA; Sherman S; Tindle HA; Shireman TI; Shelley D; Waiwaiole L; Cummins S
Am J Prev Med; 2016 Oct; 51(4):630-6. PubMed ID: 27647063
[TBL] [Abstract][Full Text] [Related]
26. Study characteristics impacted the pragmatism of randomized controlled trial published in nursing: a meta-epidemiological study.
Devos F; Foissac F; Bouazza N; Ancel PY; Tréluyer JM; Chappuy H
J Clin Epidemiol; 2019 Dec; 116():18-25. PubMed ID: 31374332
[TBL] [Abstract][Full Text] [Related]
27. Analysis of the characteristics and the degree of pragmatism exhibited by pragmatic-labelled trials of antineoplastic treatments.
Saesen R; Depreytere K; Krupianskaya K; Langeweg J; Verheecke J; Lacombe D; Huys I
BMC Med Res Methodol; 2023 Jun; 23(1):148. PubMed ID: 37355603
[TBL] [Abstract][Full Text] [Related]
28. Making clinical trials more relevant: improving and validating the PRECIS tool for matching trial design decisions to trial purpose.
Loudon K; Zwarenstein M; Sullivan F; Donnan P; Treweek S
Trials; 2013 Apr; 14():115. PubMed ID: 23782862
[TBL] [Abstract][Full Text] [Related]
29. How pragmatic are randomized trials of remdesivir and favipiravir for in-hospital treatment of COVID-19: a descriptive methodological review of trial design using the PRECIS-2 framework.
Sharma T; Qamar I; Zwarenstein M
J Clin Epidemiol; 2022 Dec; 152():193-200. PubMed ID: 36265553
[TBL] [Abstract][Full Text] [Related]
30. Integrative Oncology Trials in the Real World: Assessing the Pragmatism of an Ongoing Integrative Oncology Trial of Mindfulness and T'ai Chi/Qigong.
Carlson LE; Oberoi DV; Qureshi M; Subnis U
J Altern Complement Med; 2018; 24(9-10):926-932. PubMed ID: 30247962
[TBL] [Abstract][Full Text] [Related]
31. Pilot and feasibility studies for pragmatic trials have unique considerations and areas of uncertainty.
Chan CL; Taljaard M; Lancaster GA; Brehaut JC; Eldridge SM
J Clin Epidemiol; 2021 Oct; 138():102-114. PubMed ID: 34229091
[TBL] [Abstract][Full Text] [Related]
32. Designing a valid randomized pragmatic primary care implementation trial: the my own health report (MOHR) project.
Krist AH; Glenn BA; Glasgow RE; Balasubramanian BA; Chambers DA; Fernandez ME; Heurtin-Roberts S; Kessler R; Ory MG; Phillips SM; Ritzwoller DP; Roby DH; Rodriguez HP; Sabo RT; Sheinfeld Gorin SN; Stange KC;
Implement Sci; 2013 Jun; 8():73. PubMed ID: 23799943
[TBL] [Abstract][Full Text] [Related]
33. Systematic Review of the "Pragmatism" of Pragmatic Critical Care Trials.
Palakshappa JA; Gibbs KW; Lannan MT; Cranford AR; Taylor SP
Crit Care Explor; 2022 Jul; 4(7):e0738. PubMed ID: 35923590
[TBL] [Abstract][Full Text] [Related]
34. A systematic review of eHealth cancer prevention and control interventions: new technology, same methods and designs?
Sanchez MA; Rabin BA; Gaglio B; Henton M; Elzarrad MK; Purcell P; Glasgow RE
Transl Behav Med; 2013 Dec; 3(4):392-401. PubMed ID: 24294327
[TBL] [Abstract][Full Text] [Related]
35. Designing provider-focused implementation trials with purpose and intent: introducing the PRECIS-2-PS tool.
Norton WE; Loudon K; Chambers DA; Zwarenstein M
Implement Sci; 2021 Jan; 16(1):7. PubMed ID: 33413489
[TBL] [Abstract][Full Text] [Related]
36. [The PRECIS-2 tool: designing trials that are fit for purpose].
Hu GP; Zhan SY
Zhonghua Liu Xing Bing Xue Za Zhi; 2018 Feb; 39(2):222-226. PubMed ID: 29495210
[TBL] [Abstract][Full Text] [Related]
37. The PRECIS-2 tool has good interrater reliability and modest discriminant validity.
Loudon K; Zwarenstein M; Sullivan FM; Donnan PT; Gágyor I; Hobbelen HJSM; Althabe F; Krishnan JA; Treweek S
J Clin Epidemiol; 2017 Aug; 88():113-121. PubMed ID: 28603007
[TBL] [Abstract][Full Text] [Related]
38. Generalizability of randomized controlled trials in primary health care: Applying the PRECIS-2 tool on published protocols.
Papagiannopoulou E; Laiou E; Tatsi C; Dimakopoulos G; Ntzani EE; Siamopoulos K; Tatsioni A
J Eval Clin Pract; 2023 Mar; 29(2):253-262. PubMed ID: 36072984
[TBL] [Abstract][Full Text] [Related]
39. The value of the pragmatic-explanatory continuum indicator summary wheel in an ongoing study: the bullous pemphigoid steroids and tetracyclines study.
Bratton DJ; Nunn AJ; Wojnarowska F; Kirtschig G; Sandell A; Williams HC
Trials; 2012 Apr; 13():50. PubMed ID: 22540678
[TBL] [Abstract][Full Text] [Related]
40. How can clinical practices pragmatically increase physical activity for patients with type 2 diabetes? A systematic review.
Luoma KA; Leavitt IM; Marrs JC; Nederveld AL; Regensteiner JG; Dunn AL; Glasgow RE; Huebschmann AG
Transl Behav Med; 2017 Dec; 7(4):751-772. PubMed ID: 28589531
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
